 BURLINGAME, Calif., Sept. 07, 2021 GLOBE NEWSWIRE -- Corvus Pharmaceuticals, Inc. NASDAQ: CRVS, a clinical-stage biopharmaceutical company, today announced that the Companys management will participate in two upcoming investor conferences in September: 